You have full text access to this OnlineOpen article

Hepatology

Cover image for Vol. 54 Issue 4

October 2011

Volume 54, Issue 4

Pages 1115–1491

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
  2. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
      Apoptosis: A barrier against cancer no more? (pages 1121–1124)

      Florian Baumgartner and Andreas Villunger

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24637

    3. You have full text access to this OnlineOpen article
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection (pages 1127–1134)

      Francesco Marabita, Alessio Aghemo, Stella De Nicola, Maria G. Rumi, Cristina Cheroni, Rossana Scavelli, Marco Crimi, Roberta Soffredini, Sergio Abrignani, Raffaele De Francesco and Massimo Colombo

      Article first published online: 19 AUG 2011 | DOI: 10.1002/hep.24503

    2. You have full text access to this OnlineOpen article
      Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees (pages 1135–1148)

      Heidi Barth, Jolanta Rybczynska, Romuald Patient, Youkyung Choi, Ronda K. Sapp, Thomas F. Baumert, Kris Krawczynski and T. Jake Liang

      Article first published online: 11 AUG 2011 | DOI: 10.1002/hep.24489

    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article
      Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations (pages 1157–1166)

      Christoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, Julia Schmidt, Katja Nitschke, John Sidney, Célia Caillet-Saguy, Marco Binder, Nadine Kersting, Michael W. Kemper, Karen A. Power, Susan Ingber, Laura L. Reyor, Kelsey Hills-Evans, Arthur Y. Kim, Georg M. Lauer, Volker Lohmann, Alessandro Sette, Matthew R. Henn, Stéphane Bressanelli, Robert Thimme and Todd M. Allen

      Article first published online: 6 SEP 2011 | DOI: 10.1002/hep.24541

    5. You have full text access to this OnlineOpen article
    6. You have full text access to this OnlineOpen article
    7. You have full text access to this OnlineOpen article
    8. You have full text access to this OnlineOpen article
  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study (pages 1208–1216)

      Neeraj Bhala, Paul Angulo, David van der Poorten, Eric Lee, Jason M. Hui, Giorgio Saracco, Leon A. Adams, Phunchai Charatcharoenwitthaya, Joanne H. Topping, Elisabetta Bugianesi, Christopher P. Day and Jacob George

      Article first published online: 9 AUG 2011 | DOI: 10.1002/hep.24491

    2. You have full text access to this OnlineOpen article
      Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice (pages 1217–1226)

      Alexandre Louvet, Fatima Teixeira-Clerc, Marie-Noële Chobert, Vanessa Deveaux, Catherine Pavoine, Andreas Zimmer, Françoise Pecker, Ariane Mallat and Sophie Lotersztajn

      Article first published online: 6 SEP 2011 | DOI: 10.1002/hep.24524

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma (pages 1227–1236)

      Deshui Jia, Lin Wei, Weijie Guo, Ruopeng Zha, Meiyan Bao, Zhiao Chen, Yingjun Zhao, Chao Ge, Fangyu Zhao, Taoyang Chen, Ming Yao, Jinjun Li, Hongyang Wang, Jianren Gu and Xianghuo He

      Article first published online: 24 AUG 2011 | DOI: 10.1002/hep.24495

    2. You have full text access to this OnlineOpen article
    3. You have full text access to this OnlineOpen article
      PUMA–mediated apoptosis drives chemical hepatocarcinogenesis in mice (pages 1249–1258)

      Wei Qiu, Xinwei Wang, Brian Leibowitz, Wancai Yang, Lin Zhang and Jian Yu

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24516

    4. You have full text access to this OnlineOpen article
      Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells (pages 1259–1272)

      Wen Sun, Jin Ding, Kun Wu, Bei-Fang Ning, Wen Wen, Han-Yong Sun, Tao Han, Lei Huang, Li-Wei Dong, Wen Yang, Xing Deng, Zhong Li, Meng-Chao Wu, Gen-Sheng Feng, Wei-Fen Xie and Hong-Yang Wang

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24530

    5. You have full text access to this OnlineOpen article
      Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study (pages 1273–1281)

      Shinji Tanaka, Kaoru Mogushi, Mahmut Yasen, Daisuke Ban, Norio Noguchi, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Hiroshi Tanaka, Masakazu Yamamoto, Norihiro Kokudo, Tadatoshi Takayama, Seiji Kawasaki, Michiie Sakamoto and Shigeki Arii

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24536

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart (pages 1282–1292)

      Michele Miragoli, Siti H. Sheikh Abdul Kadir, Mary N. Sheppard, Nicoló Salvarani, Matilda Virta, Sarah Wells, Max J. Lab, Viacheslav O. Nikolaev, Alexey Moshkov, William M. Hague, Stephan Rohr, Catherine Williamson and Julia Gorelik

      Article first published online: 1 AUG 2011 | DOI: 10.1002/hep.24492

    2. You have full text access to this OnlineOpen article
      Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis (pages 1293–1302)

      Masanobu Tsuda, Yoko M. Ambrosini, Weici Zhang, Guo-Xiang Yang, Yugo Ando, Guanghua Rong, Koichi Tsuneyama, Kosuke Sumida, Shinji Shimoda, Christopher L. Bowlus, Patrick S.C. Leung, Xiao-Song He, Ross L. Coppel, Aftab A. Ansari, Zhe-Xiong Lian and M. Eric Gershwin

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24526

    3. You have full text access to this OnlineOpen article
      Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCOmath image output (pages 1303–1312)

      Anna Baghdasaryan, Thierry Claudel, Judith Gumhold, Dagmar Silbert, Luciano Adorini, Aldo Roda, Stefania Vecchiotti, Frank J. Gonzalez, Kristina Schoonjans, Mario Strazzabosco, Peter Fickert and Michael Trauner

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24537

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era (pages 1313–1321)

      Carl L. Berg, Robert M. Merion, Tempie H. Shearon, Kim M. Olthoff, Robert S. Brown Jr., Talia B. Baker, Gregory T. Everson, Johnny C. Hong, Norah Terrault, Paul H. Hayashi, Robert A. Fisher and James E. Everhart

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24494

  8. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity (pages 1322–1332)

      Munzir M.E. Ahmed, Tao Wang, Yu Luo, Shuilong Ye, Qiao Wu, Zongsheng Guo, Bill D. Roebuck, Thomas R. Sutter and James Y. Yang

      Article first published online: 6 SEP 2011 | DOI: 10.1002/hep.24493

    2. You have full text access to this OnlineOpen article
      Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury (pages 1333–1343)

      Michael D. Thompson, Emily D. Wickline, William B. Bowen, Amy Lu, Sucha Singh, Amalea Misse and Satdarshan P.S. Monga

      Article first published online: 21 JUL 2011 | DOI: 10.1002/hep.24506

    3. You have full text access to this OnlineOpen article
  9. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer (pages 1351–1359)

      Raymond D. Hickey, Joseph B. Lillegard, James E. Fisher, Travis J. McKenzie, Sean E. Hofherr, Milton J. Finegold, Scott L. Nyberg and Markus Grompe

      Article first published online: 9 AUG 2011 | DOI: 10.1002/hep.24490

    2. You have full text access to this OnlineOpen article
      Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo (pages 1360–1370)

      Vishakha S. Bhave, Shirish Paranjpe, William C. Bowen, Shashikiran Donthamsetty, Aaron W. Bell, Jaspal S. Khillan and George K. Michalopoulos

      Article first published online: 24 AUG 2011 | DOI: 10.1002/hep.24507

    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article
    5. You have full text access to this OnlineOpen article
      Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans (pages 1388–1397)

      Sujit S. Nair, Anitha Bommana, Suresh B. Pakala, Kazufumi Ohshiro, Amanda J. Lyon, Sutas Suttiprapa, Maria V. Periago, Thewarach Laha, Peter J. Hotez, Jeffrey M. Bethony, Banchob Sripa, Paul J. Brindley and Rakesh Kumar

      Article first published online: 6 SEP 2011 | DOI: 10.1002/hep.24518

    6. You have full text access to this OnlineOpen article
      Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice (pages 1398–1409)

      Kristina M. Mueller, Jan-Wilhelm Kornfeld, Katrin Friedbichler, Leander Blaas, Gerda Egger, Harald Esterbauer, Peter Hasselblatt, Michaela Schlederer, Susanne Haindl, Kay-Uwe Wagner, David Engblom, Guenter Haemmerle, Dagmar Kratky, Veronika Sexl, Lukas Kenner, Andrey V. Kozlov, Luigi Terracciano, Rudolf Zechner, Guenther Schuetz, Emilio Casanova, J. Andrew Pospisilik, Markus H. Heim and Richard Moriggl

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24509

    7. You have full text access to this OnlineOpen article
    8. You have full text access to this OnlineOpen article
  10. AASLD Practice Guideline

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have free access to this content
  11. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      CXC chemokine signaling in the liver: Impact on repair and regeneration (pages 1445–1453)

      Heather L. Van Sweringen, Nozomu Sakai, Amit D. Tevar, Justin M. Burns, Michael J. Edwards and Alex B. Lentsch

      Article first published online: 29 JUN 2011 | DOI: 10.1002/hep.24457

    2. You have full text access to this OnlineOpen article
      Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve? (pages 1454–1462)

      Indra Neil Guha, Robert P. Myers, Keyur Patel and Jayant A. Talwalkar

      Article first published online: 9 AUG 2011 | DOI: 10.1002/hep.24515

  12. Diagnostic and Therapeutic Advances in Hepatology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      Drug therapy: Telaprevir (pages 1463–1469)

      Michael D. Leise, W. Ray Kim, Katherine M. Canterbury and John J. Poterucha

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24660

  13. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
      JNK: A double-edged sword in tumorigenesis (pages 1470–1472)

      Francisco Javier Cubero, Gang Zhao and Christian Trautwein

      Article first published online: 28 SEP 2011 | DOI: 10.1002/hep.24532

    2. You have full text access to this OnlineOpen article
      Border patrol intensifies for hepatitis C virus entry (pages 1472–1475)

      Erin M. McCartney, Nicholas S. Eyre and Michael R. Beard

      Article first published online: 28 SEP 2011 | DOI: 10.1002/hep.24586

    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article
  14. Image of the Month

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
  15. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guideline
    12. Reviews
    13. Diagnostic and Therapeutic Advances in Hepatology
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
      Reply (pages 1482–1483)

      Michelle Martinot-Peignoux, Tarik Asselah and Patrick Marcellin

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24585

    3. You have full text access to this OnlineOpen article
      The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C (pages 1483–1484)

      Nicole T. do O, Dennis Eurich, Christian Trautwein, Peter Neuhaus, Ulf P. Neumann and Hermann E. Wasmuth

      Article first published online: 19 AUG 2011 | DOI: 10.1002/hep.24535

    4. You have full text access to this OnlineOpen article
    5. You have full text access to this OnlineOpen article
      Hepatic stellate cell proliferation: A potential role of protein kinase R (pages 1484–1485)

      Sara Ceccarelli, Nadia Panera, Anna Alisi and Valerio Nobili

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24579

    6. You have full text access to this OnlineOpen article
      Reply (pages 1485–1486)

      Núria Tarrats, Anna Moles, Albert Morales, Carmen García-Ruiz, José C. Fernández-Checa and Montserrat Marí

      Article first published online: 27 SEP 2011 | DOI: 10.1002/hep.24640

    7. You have full text access to this OnlineOpen article
    8. You have full text access to this OnlineOpen article
      Metabolic syndrome and liver cancer: Is excess iron the link? (page 1487)

      Luca Mascitelli and Mark R. Goldstein

      Article first published online: 21 JUL 2011 | DOI: 10.1002/hep.24437

    9. You have full text access to this OnlineOpen article
      Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases (pages 1487–1489)

      Nicola Coppola, Mariantonietta Pisaturo, Salvatore Guastafierro, Gilda Tonziello, Antonello Sica, Caterina Sagnelli, Maria Giovanna Ferrara and Evangelista Sagnelli

      Article first published online: 24 AUG 2011 | DOI: 10.1002/hep.24436

    10. You have full text access to this OnlineOpen article
    11. You have full text access to this OnlineOpen article
    12. You have full text access to this OnlineOpen article

SEARCH

SEARCH BY CITATION